SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) June 3, 2002
DISEASE SCIENCES, Inc.
(Exact name of registrant as specified in its charter)
Delaware 0-27865 13-264091
--------------------------------------------------------------------------------
(State or other (Commission (IRS Employer
jurisdiction of File Number) Identification No.)
formation)
620 Herndon Parkway, Suite 360, Herndon, Virginia 20170
-------------------------------------------------- ---------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (703) 563-6565
Item 8. Change in Fiscal Year
Disease Sciences, Inc. determined at a meeting of its Board of Directors held on
June 3, 2002 to change its fiscal year from the current time period February 1
to January 31 to a fiscal year that starts on October 1 and ends on September
30. The date on which the new fiscal year ends will be September 30, 2002.
A transition report will not be required. A Form 10QSB for the period October 1,
2001 through March 31, 2002 will be filed as soon as possible but not later than
July 15, 2002.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly authorized and caused the undersigned to sign this report on
the registrant's behalf.
DISEASE SCIENCES, INC.
By: /s/ John R. Signorello
------------------------
Name: John R. Signorello
Title: CEO
Dated: June 17, 2002